Table 2.
Details of the primary antibodies used in the study
| Antibody | Company | Cat. Number; RRID | WB dilution | IF/IHC dilution |
|---|---|---|---|---|
| ACTB | Sigma-Aldrich | A3854; RRID:AB_262011 | 1:40,000 | |
| CTSD | Santa Cruz Biotech. | sc-6486; RRID:AB_637896 | 1:500 | |
| CYC | BD Biosciences | 556,433; RRID:AB_396417 | 1:1000 | |
| CYC | BD Biosciences | 556,432; RRID:AB_396416 | 1:300 | |
| GAPDH | Abcam | ab8245; RRID:AB_2107448 | 1:5000 | |
| GST | Santa Cruz Biotech. | sc-374,171; RRID:AB_11008206 | 1:1000 | 1:300 |
| HDAC6 | Santa Cruz Biotech. | sc-5258; RRID:AB_2116625 | 1:300 | |
| LAMP2 | Abcam | ab13524; RRID:AB_2134736 | 1:300 | |
| LC3B | Cell Signaling | #2775S; RRID:AB_915950 | 1:1000 | 1:300 |
| MFN2 | Santa Cruz Biotech. | sc-50,331; RRID:AB_2142754 | 1:500 | |
| OPTN | Santa Cruz Biotech. | sc-166,576; RRID:AB_2156554 | 1:1000 | 1:300 |
| SQSTM1 | Abcam | ab91526; RRID:AB_2050336 | 1:1000 | 1:500 |
| PARL | Aviva Systems Biology | ARP44851_P050; RRID:AB_1294596 | 1:1000 | |
| Parkin | Abcam | Ab77924; RRID:AB_1566559 | 1:1000 | 1:1000 |
| PDH | Abcam | ab110330; RRID:AB_10858459 | 1:1000 | |
| PGC-1α | Millipore | ST1202; RRID:AB_2237237 | 1:1000 | |
| PINK1 | Abcam | ab23707; RRID:AB_447627 | 1:1000 | 1:500 |
| PINK1 | Novus Biotech. | BC100–494; RRID:AB_10127658 | 1:1000 | |
| RHOT1 | Biorbyt | orb165560 | 1:1000 | |
| p-TBK1 (Ser172) | Cell Signaling | #5483; RRID:AB_10693472 | 1:1000 | |
| TBK1 | GeneTex | GTX113057; RRID:AB_11174793 | 1:1000 | |
| TFAM | GeneTex | GTX103231; RRID:AB_11176720 | 1:1000 | |
| TOMM20 | Santa Cruz Biotech. | sc-11,415; RRID:AB_2207533 | 1:500 | 1:300 |
| Ub | Santa Cruz Biotech. | sc-9133; RRID:AB_2180553 | 1:500 | |
| K63-Ub | Affymetrix | 14–6077 | 1:500 | 1:300 |
| ULK1 | Santa Cruz Biotech. | sc-33,182; RRID:AB_2214706 | 1:250 |